# Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™

> **NCT00600327** · PHASE3 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 488 (actual)

## Conditions studied

- Transient Ischemic Attack
- Thromboembolic Stroke
- Stroke Prevention

## Interventions

- **DEVICE:** EndoTex™ NexStent™
- **DEVICE:** Filter Wire EZ™

## Key facts

- **NCT ID:** NCT00600327
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** 2005-03
- **Final completion:** 2007-06
- **Target enrollment:** 488 (ACTUAL)
- **Last updated:** 2008-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00600327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00600327, "Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00600327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*